Keytruda Archives - Pharmaphorum

Merck & Co’s Keytruda shows potential in head and neck cancer use

https://pharmaphorum.com/news/keytruda-shows-promise-first-line-skin-cancer-treatment/

FDA approves Keytruda in cervical cancer

https://pharmaphorum.com/news/fda-approves-keytruda-cervical-cancer/

ASCO 2018 Preview – what to expect from this year’s conference

https://pharmaphorum.com/views-and-analysis/asco-2018-preview-conference/

Updates on Keytruda and future potential therapies advancements in Immuno-Oncology

https://pharmaphorum.com/partner-content/updates-on-keytruda-and-future-potential-therapies-advancements-in-immuno-oncology/

Moderna and Merck expand partnership to develop new cancer vaccines

https://pharmaphorum.com/news/moderna-and-merck-expand-partnership-to-develop-new-cancer-vaccines/

Merck shows canny cancer strategy in $5.76bn Eisai milestones deal

https://pharmaphorum.com/news/merck-co-eisai-forge-5-76bn-cancer-drug-deal/

Its Herceptin biosimilar nearing launch, Celltrion begins work on Keytruda copy

https://pharmaphorum.com/news/herceptin-biosimilar-nearing-launch-celltrion-begins-work-keytruda-copy/

Keytruda not enough to lift Merck – so will it turn to M&A?

https://pharmaphorum.com/news/keytruda-growth-offsets-mercks-diabetes-decline/

Keytruda approved for bladder cancer in Europe, first to prove survival benefit

https://pharmaphorum.com/news/keytruda-approved-bladder-cancer-europe-first-prove-survival-benefit/

Search